Doctors Note Logo

Published on: 7/24/2025

What is the FDA status of enobosarm for obesity treatment?

Enobosarm is not currently approved by the FDA for treating obesity.

answer background

Explanation

Enobosarm is a selective androgen receptor modulator (SARM) that has been studied for various uses, but there is no information in the provided references about its approval by the FDA for obesity treatment.

Clinical study designs for enobosarm have been discussed, but they do not mention obesity as a primary focus. Some discussions talk about selective androgen receptor modulators like enobosarm as potential future treatments, but without specifying FDA approval for obesity. Additionally, there have been reports highlighting cases of liver injury linked to enobosarm, suggesting that safety concerns may exist.

Thus, based on the available references, enobosarm is not approved by the FDA for obesity treatment. Further research and clinical trials would be needed to evaluate its safety and efficacy for this purpose.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.